MAPK Pathway Inhibitors
Explore 927+ research-grade small molecules targeting the MAPK/ERK signaling cascade. RAS, RAF, MEK, ERK, p38, and JNK inhibitors for your signal transduction research.
Featured MAPK Pathway Inhibitors
Popular research compounds for studying MAPK/ERK signaling. Each product includes detailed datasheets and technical specifications.
Browse by Target
Explore MAPK pathway compounds organized by molecular target. Click any target to view matching products.
MAPK Signaling in Research
Understanding the mitogen-activated protein kinase cascade and its role in cellular regulation.
The MAPK (mitogen-activated protein kinase) signaling pathway is one of the most extensively studied signal transduction cascades in cell biology. It plays essential roles in regulating cell growth, differentiation, proliferation, and apoptosis through a series of phosphorylation events involving kinases such as RAF, MEK, and ERK.
Dysregulation of MAPK signaling has been implicated in numerous diseases, particularly cancer, where mutations in RAS, BRAF, and MEK drive uncontrolled cell proliferation. Small molecule inhibitors targeting this pathway have become critical tools for studying oncogenic signaling and developing targeted therapies in preclinical models.
Our collection includes inhibitors of all major MAPK pathway nodes: RAS inhibitors, RAF inhibitors (targeting BRAF and CRAF), MEK1/2 inhibitors, ERK1/2 inhibitors, p38 MAPK inhibitors, and JNK inhibitors, enabling comprehensive pathway interrogation in your in vitro research.
Comprehensive MAPK Pathway Tools
From well-characterized reference compounds like sorafenib and trametinib to novel chemical probes, our MAPK pathway collection provides the tools you need for signal transduction research. Each compound is supplied with full characterization data and quality documentation.
All products are suitable for in vitro research applications including kinase assays, cell-based signaling studies, pathway mapping, and combination screening experiments.
Why Order from Immunomart?
Your trusted source for research-grade MAPK pathway inhibitors and small molecules.
Related Pathway Collections
Explore our complete range of small molecule collections organized by signaling pathway.
Frequently Asked Questions
What are MAPK pathway inhibitors?
MAPK pathway inhibitors are small molecules that target components of the mitogen-activated protein kinase signaling cascade, including RAF, MEK, ERK, p38, and JNK kinases. These compounds are widely used in cancer research and signal transduction studies in vitro.
What targets are available in this collection?
This collection includes 927+ compounds targeting 30+ distinct molecular targets involved in MAPK signaling, including RAS, RAF, MEK, ERK, p38 MAPK, JNK, and many more.
Are these compounds suitable for research use?
Yes, all compounds in this collection are research-grade and intended for in vitro studies only. They are not for human or veterinary clinical use.
How quickly can I receive my order?
For in-stock items, delivery to the US typically takes 2 to 5 business days, and to Canada and Europe 5 to 10 business days. Worldwide shipping is available for all products.
Do you provide technical datasheets?
Yes, technical datasheets are available for all products. You can access them directly from each product listing or by clicking the Datasheet button on featured compounds.
